NEXI
Income statement / Annual
Last year (2023), NexImmune, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2023, NexImmune, Inc.'s net income was -$32.34 M.
See NexImmune, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$1.02 M
|
$1.50 M
|
$870.29 K
|
$618.99 K
|
$436.37 K
|
$204.65 K
|
| Gross Profit |
-$1.02 M
|
-$1.50 M
|
-$870.29 K
|
-$618.99 K
|
-$436.37 K
|
-$204.65 K
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$18.26 M
|
$47.15 M
|
$37.46 M
|
$17.84 M
|
$15.17 M
|
$8.00 M
|
| General & Administrative Expenses |
$13.00 B
|
$15.93 M
|
$15.80 M
|
$10.01 M
|
$5.71 M
|
$5.24 M
|
| Selling & Marketing Expenses |
-$12.99 B
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$9.91 M
|
$15.93 M
|
$15.80 M
|
$10.01 M
|
$5.71 M
|
$5.24 M
|
| Other Expenses |
$0.00
|
-$1.50 M
|
-$870.29 K
|
-$618.99 K
|
$0.00
|
$136.79 K
|
| Operating Expenses |
$28.17 M
|
$61.59 M
|
$52.39 M
|
$27.23 M
|
$20.89 M
|
$13.24 M
|
| Cost And Expenses |
$29.19 M
|
$63.08 M
|
$53.26 M
|
$27.85 M
|
$20.89 M
|
$13.24 M
|
| Interest Income |
$698.40 K
|
$664.37 K
|
$52.51 K
|
$20.84 K
|
$246.78 K
|
$272.44 K
|
| Interest Expense |
$0.00
|
$0.00
|
$905.33 K
|
$1.68 M
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$1.02 M
|
$1.50 M
|
$870.29 K
|
$618.99 K
|
$436.37 K
|
$204.65 K
|
| EBITDA |
-$28.17 M |
-$61.01 M |
-$49.13 M |
-$27.56 M |
-$20.45 M |
-$13.04 M |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
-$3.15 M
|
$576.69 K
|
$2.35 M
|
-$2.01 M
|
$339.06 K
|
$409.22 K
|
| Income Before Tax |
-$32.34 M
|
-$62.51 M
|
-$50.90 M
|
-$29.87 M
|
-$20.55 M
|
-$12.83 M
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00
|
-$576.69 M
|
$843.92 K
|
$1.77 M
|
-$246.78 K
|
$0.00
|
| Net Income |
-$32.34 M
|
$514.18 M
|
-$51.75 M
|
-$31.64 M
|
-$20.30 M
|
-$12.83 M
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| EPS |
-30.82 |
534.29 |
-56.67 |
-34.76 |
-22.53 |
-14.25 |
| EPS Diluted |
-30.82 |
534.29 |
-56.67 |
-34.76 |
-22.53 |
-14.25 |
| Weighted Average Shares Out |
$1.05 M
|
$962.36 K
|
$913.16 K
|
$910.31 K
|
$900.86 K
|
$900.86 K
|
| Weighted Average Shares Out Diluted |
$1.05 M
|
$962.36 K
|
$913.16 K
|
$910.31 K
|
$900.86 K
|
$900.86 K
|
| Link |
|
|
|
|
|
|
